FTC ends Solodyn probe into Impax, Medicis, Sandoz


The following article first appeared on Dec. 2 on MLex. For more information on MLex, including getting access to its exclusive content, please contact¬ sales@mlex.com. ¬ The Federal Trade Commission has closed its investigation into whether Impax Laboratories, Medicis Pharmaceutical and Sandoz engaged in anticompetitive conduct intended to